Related Experiment Video
Updated: Jan 27, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Opioid Sensitivity in Children with and without Obstructive Sleep Apnea
Michael C Montana1, Lindsay Juriga, Anshuman Sharma
1From the Department of Anesthesiology, Washington University in St. Louis, School of Medicine, St. Louis, Missouri (M.C.M., L.J., A.S., E.D.K.) the Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina (E.D.K.).
Insights
Children with obstructive sleep apnea do not show increased sensitivity to remifentanil, a common opioid. This study found no significant differences in miotic or respiratory effects between children with and without obstructive sleep apnea when given remifentanil.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
- Sleep Medicine
Background:
- Opioids are frequently used for pain relief during surgery.
- Concerns exist regarding increased opioid sensitivity and respiratory risks in children with obstructive sleep apnea (OSA).
- Previous assumptions about heightened opioid effects in pediatric OSA patients lack rigorous testing.
Purpose of the Study:
- To investigate if children with obstructive sleep apnea exhibit increased pharmacodynamic sensitivity to remifentanil.
- To compare the miotic and respiratory depressant effects of remifentanil in children with and without OSA.
Main Methods:
- Administered fixed-rate remifentanil infusions to children aged 8-14 years with or without OSA.
- Measured plasma remifentanil concentrations using liquid chromatography-mass spectrometry.
- Assessed remifentanil effects by monitoring miosis, respiratory rate, and end-expired carbon dioxide.
Main Results:
- Remifentanil induced miosis in both groups without significant differences in the concentration-effect relationship.
- No significant alterations in respiratory rate or end-expired carbon dioxide were observed in either group.
- The tested doses of remifentanil did not differentially affect ventilatory parameters based on OSA status.
Conclusions:
- Children with obstructive sleep apnea do not display increased sensitivity to the miotic effects of remifentanil.
- Remifentanil administration did not impact respiratory parameters differently in children with or without OSA.
- The findings challenge prior assumptions regarding heightened opioid sensitivity in pediatric OSA.
Background:
Opioids are a mainstay of perioperative analgesia. Opioid use in children with obstructive sleep apnea is challenging because of assumptions for increased opioid sensitivity and assumed risk for opioid-induced respiratory depression compared to children without obstructive sleep apnea. These assumptions have not been rigorously tested. This investigation tested the hypothesis that children with obstructive sleep apnea have an increased pharmacodynamic sensitivity to the miotic and respiratory depressant effects of the prototypic μ-opioid agonist remifentanil.
Methods:
Children (8 to 14 yr) with or without obstructive sleep apnea were administered a 15-min, fixed-rate remifentanil infusion (0.05, 0.1, or 0.15 μg · kg · min). Each dose group had five patients with and five without obstructive sleep apnea. Plasma remifentanil concentrations were measured by tandem liquid chromatography mass spectrometry. Remifentanil effects were measured via miosis, respiratory rate, and end-expired carbon dioxide. Remifentanil pharmacodynamics (miosis vs. plasma concentration) were compared in children with or without obstructive sleep apnea.
Results:
Remifentanil administration resulted in miosis in both non-obstructive sleep apnea and obstructive sleep apnea patients. No differences in the relationship between remifentanil concentration and miosis were seen between the two groups at any of the doses administered. The administered dose of remifentanil did not affect respiratory rate or end-expired carbon dioxide in either group.
Conclusions:
No differences in the remifentanil concentration-miosis relation were seen in children with or without obstructive sleep apnea. The dose and duration of remifentanil administered did not alter ventilatory parameters in either group.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Opioid Analgesics: Morphine and Other Natural Cogeners
Stages of Sleep
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...

